Lupin launches diagnostics business in India

10 Dec 2021 Evaluate

Lupin has launched diagnostics business in India. As part of its strategy to provide integrated healthcare in India, Lupin Diagnostics, a wholly owned subsidiary of Lupin has formally commenced operations. With healthcare playing an increasingly important role, Lupin Diagnostics' goal is to provide quality diagnostics services to doctors, patients and consumers. The company has established a state-of the-art 45,000 sq. ft National Reference Laboratory in Navi Mumbai.

With world-class equipments, experienced doctors assisted by trained technologists, and stringent quality control protocols, Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×